Skip to main content

Table 2 E-cadherin expression in early stage IDCs

From: E-cadherin expression phenotypes associated with molecular subtypes in invasive non-lobular breast cancer: evidence from a retrospective study and meta-analysis

Characteristics No. of patients E-cadherin χ 2 (P value)
Negative/low Positive
Histologic grade
 I 13 2 11 0.79 (0.673)
 II 107 17 90
 III 36 8 28
Tumor stage
 T1 77 15 62 0.50 (0.479)
 T2 79 12 67
Nodal stage
 Negative 96 20 76 2.17 (0.141)
 Positive 60 7 53
TNM stage
 I 50 11 39 1.13 (0.287)
 II 106 16 90
ER
 Negative 52 13 39 3.23 (0.073)
 Positive 104 14 90
PR
 Negative 82 16 66 0.59 (0.444)
 Positive 74 11 63
HER2
 Negative 129 24 105 0.43 (0.512)
 Positive 27 3 24
Ki67
 Negative 40 6 34 0.20 (0.655)
 Positive 116 21 95
Molecular subtypes
 Luminal A 30 3 27 7.85 (0.049)
 Luminal B 74 11 63
 HER2-enriched 14 1 13
 TNBC 38 12 26
  1. IDC invasive ductal carcinoma of the breast, TNBC triple-negative breast cancer